There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals...
CA-based Cercle, an AI company that unlocks women’s healthcare data at scale into insights for optimal patient and business outcomes, announced it has raised $6 million in seed funding.
There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals...
Strider Technologies, the leading provider of strategic intelligence, has closed $55 million in Series C funding. With this funding, Strider will continue advancing its AI-driven capabilities into its integrated global intelligence platform, expand operations to new geographies in Europe and Asia, and more aggressively address the public sector market.
Superluminal Medicines, Inc., “The Membrane Company” using generative biology, chemistry, and machine learning approaches to revolutionize the speed and accuracy of how medicines are created, today announced the closing of a $120 million Series A funding round.
Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid tumors, announced the close of an oversubscribed $325 million Series C financing round.
RYSE Asset Management, the healthcare investor supporting innovative early-stage companies transforming lives, announced it has participated in a double-digit million investment round for Curio Digital Therapeutics Inc., (Curio), an innovative US company treating postpartum depression (PPD) and other underserved women’s mental health conditions.
ModelOp, the leading AI Governance software for enterprises, raised $10 million in series B equity financing led by Baird Capital with participation from existing investors. ModelOp has pioneered AI Governance software and automation, working directly with Fortune 500 companies to address the needs of enterprise executives, governance teams, and business leaders.
Cents, the largest leading all-in-one business management platform powering the way garment care SMBs grow, manage, and understand their businesses, announced the close of its $40M Series B funding round.
Shinobi Therapeutics, the biotechnology company developing a new class of immune evasive iPS cell therapies has been awarded up to $59M in non-dilutive grant funding by the Japanese Agency for Medical Research and Development (AMED).
